Effects of low-dose Aspirin in bipolar disorder – a randomized controlled trial

BD is increasingly conceived as a multisystem disorder with inflammation confirmed to be involved in the pathogenesis. Emerging yet compelling data converge to suggest that low-dose Aspirin may protect against its onset and deterioration. The present study is the first double-blinded randomized placebo-controlled trial investigating whether low-dose Aspirin versus placebo as add-on to standard treatment improves mood stabilization and other critical patient outcomes in 250 subjects with BD, and whether its principal effects are antimanic, antidepressant or prophylactic against relapse. ​

For further information, please contact: Caroline Fussing
Mail: caroline.fussing.bruun@regionh.dk​